A change in the mix of pharmaceutical products dispensed to patients has driven down revenue at Bupa Home Healthcare. The company, which was formed from Bupa’s acquisition of Clinovia five years ago, reported a 4.4% decline in turnover to £194.7m in the year ended 31 December 2010. Nevertheless, gross profit improved to £31m from £30m…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
